| NCT Number | NCT06212947 |
| Lead Sponsor | BioMarin Pharmaceutical |
| Conditions | Hypochondroplasia |
| Enrollment | 400 participants |
| Start Date | 2023-11-27 |
| Primary Completion | 2043-12-31 (estimated) |
| Study Completion | 2043-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-04-03 |